Literature DB >> 9487533

The business of pharmacogenomics.

A Persidis1.   

Abstract

Mesh：

Year:  1998        PMID： 9487533     DOI： 10.1038/nbt0298-209

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Assessing the cost-effectiveness of pharmacogenomics.

Authors:  D L Veenstra; M K Higashi; K A Phillips
Journal:  AAPS PharmSci       Date:  2000

2.  Human membrane transporter database: a Web-accessible relational database for drug transport studies and pharmacogenomics.

Authors:  Q Yan; W Sadée
Journal:  AAPS PharmSci       Date:  2000

Review 3.  Pharmacogenetics: the therapeutic drug monitoring of the future?

Authors:  M H Ensom; T K Chang; P Patel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

4.  Genetic variation and pharmacogenomics: concepts, facts, and challenges.

Authors:  Margret R Hoehe; Thomas Kroslak
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

5.  Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes.

Authors:  Rama Saad; Mariam R Rizkallah; Ramy K Aziz
Journal:  Gut Pathog       Date:  2012-11-30       Impact factor: 4.181
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.